D. O. Olaleye, T. O. Harry and G. N. Odaibo, “The Virology and Dynamics of the Epidemic,” In: O. Adeyi, P. J. Kanki, O. Odutolu and J. A. Idoko, Eds., AIDS in Nigeria: A Nation on the Threshold, Harvard Center for Population and Development, Cambridge, 2006, pp. 37-66.
 S. T. Meloni, A. Ojesina and D. O. Olaleye, “The Molecular Epidemiology of HIV,” In: O. Adeyi, P. J. Kanki, O. Odutolu and J. A. Idoko, Eds., AIDS in Nigeria: A Nation on the Threshold, Harvard Center for Population and Development, Cambridge, 2006, pp. 67-92.
 D. Olaleye, L. Bernstein, C. Ekwezor et al., “Prevalence of Human Immunodeficiency Virus Type 1 and 2 Infections in Nigeria,” The Journal of Infectious Diseases, Vol. 167, No. 3, 1993, pp. 710-714. doi:10.1093/infdis/167.3.710
 T. Harry, O. Ekanna, J. Chikwen et al., “Seroepidemiology of Human Immunodeficiency Virus Infection in Borno State of Nigeria by Sentinel Sueveillance,” Journal of Acquired Immune Deficiency Syndrome, Vol. 6, No. 1, 1993, pp. 99-103.
 S Jaffar, A. D. Grant, J. Whitworth, P. G. Smith and H. Whittle, “The Natural History of HIV-1 and HIV-2 Infections in Adults in Africa: A Literature Review,” Bulletin of World Health Organization, Vol. 82, No. 6, 2004, pp. 462-469.
 A. G. Poulsen, P. Aaby, O. Larsen et al., “9-Year HIV-2-Associated Mortality in an Urban Community in Bissau,” West African Lancet, Vol. 349, No. 9056, 1997, pp. 911-914. doi:10.1016/S0140-6736(96)04402-9
 H. Whittle, J. Morris and J. Todd, T. Corrah, S. Sabally, J. Bangali, P. T. Ngom, M. Rolfe and A. Wilkins, “HIV-2 Infected Patients Survive Longer than HIV-1-Infected Patients,” AIDS, Vol. 8, No. 11, 1994, pp. 1617-1620. doi:10.1097/00002030-199411000-00015
 K. Peterson, S. Jallow, S. L. Rowland-Jones and T. I. de Siliva, “Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings,” AIDS Research and Treatment, 2011, p. 13.
 A. S. Alabi, S. Jaffar, Ariyoshi et al., “Plasma Viral Load, CD4 Cell Percentage, HLA and Survival of HIV-1, HIV-2 and Dually Infected Gambian Patients,” AIDS, Vol. 17, No. 10, 2003, pp. 1513-1520.
 S. Jallow, A. Alabi, R. Sarge-Njie et al., “Virological Response to Highly Active Antiretroviral Therapy in Patients Infected with Human Immunodeficiency Virus Type 2 (HIV-2) and Patients Dually Infected with HIV-1 and HIV-2 in the Gambia and Emergence of Drug-Resistant Variants,” Journal of Clinical Microbiology, Vol. 47, No. 7, 2009, pp. 2200-2208. doi:10.1128/JCM.01654-08
 N. K. Barry, S. Ariyoshi, S. Jaffar et al., “Low Peripheral Blood Viral HIV-2 RNA in Individuals with High CD4 Percentage Differentiates HIV-2 from HIV-1 Infection,” Journal of Human Virology, Vol. 1, 1998, pp. 457-468.
 D. K. Oladepo, E. O. Idigbe, R. O. Audu et al., “Establishment of Reference CD4 and CD8 Lymphocyte Subsets in Healthy Nigerian Adults,” Clinical and Vaccine Immunology, Vol. 16, No. 9, 2009, pp. 1374-1377. doi:10.1128/CVI.00378-08
 Federal Ministry of Health, “Abuja, Nigeria, National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults,” pp. 1-67. http://www.who.int/hiv/pub/guidelines/nigeria_art.pdf
 T. de Siliva, C. van Tienen, S. Rowland-Jones and M. Cotton, “Dual infection with HIV-1 and HIV-2: Double Trouble or Destructive Interference?” HIV Therapy, Vol. 4, No. 3, 2010, pp. 305-323. doi:10.2217/hiv.10.26